Cheryl Buxton - 31 Dec 2021 Form 4 Insider Report for HUMANIGEN, INC

Role
Director
Signature
/s/ Cameron Durrant, Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
+$15,685
Form type
4
Filing time
04 Jan 2022, 17:21:00 UTC
Next filing
29 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HGEN Stock Option (Right to Buy) Award $15,685 +5,523 $2.84 5,523 31 Dec 2021 Common Stock 5,523 $3.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option was granted to Ms. Buxton in lieu of $15,696 of cash compensation otherwise payable to Ms. Buxton in respect of her services as a director during the fourth quarter of 2021.